Rohto Pharmaceutical Co Ltd (RPHCF)
OTHER OTC:RPHCF
Holding RPHCF?
Track your performance easily

Rohto Pharmaceutical Co (RPHCF) Financial Statements

3 Followers

Rohto Pharmaceutical Co Financial Overview

Rohto Pharmaceutical Co's market cap is currently ―. The company's EPS TTM is $0.89; its P/E ratio is 24.92; and it has a dividend yield of 0.95%. Rohto Pharmaceutical Co is scheduled to report earnings on November 13, 2024, and the estimated EPS forecast is $0.23. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue¥ 65.95B-¥ 52.26B¥ 55.62B¥ 53.00B
Gross Profit¥ 38.95B-¥ 29.59B¥ 32.49B¥ 31.53B
EBIT¥ 11.79B-¥ 9.71B¥ 4.53B¥ 9.75B
EBITDA¥ 11.79B-¥ 9.71B¥ 4.53B¥ 9.75B
Net Income Common Stockholders¥ 8.45B-¥ 6.99B¥ 4.08B¥ 6.18B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments¥ 77.64B¥ 0.00¥ 77.25B¥ 72.79B¥ 67.40B
Total Assets¥ 311.83B-¥ 293.16B¥ 274.63B¥ 265.06B
Total Debt¥ 15.70B¥ 0.00¥ 20.80B¥ 21.38B¥ 20.44B
Net Debt¥ -61.94B¥ 0.00¥ -56.45B¥ -51.41B¥ -46.97B
Total Liabilities¥ 98.38B-¥ 98.32B¥ 90.80B¥ 87.66B
Stockholders Equity¥ 207.78B¥ 0.00¥ 189.13B¥ 178.28B¥ 171.41B
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in JPY

Rohto Pharmaceutical Co Earnings and Revenue History

Rohto Pharmaceutical Co Debt to Assets

Rohto Pharmaceutical Co Cash Flow

Rohto Pharmaceutical Co Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis